148 related articles for article (PubMed ID: 1354156)
41. [Continued gastric acid inhibitory therapy after Helicobacter eradication?].
Mössner J
Internist (Berl); 1997 Nov; 38(11):1105-7. PubMed ID: 9453962
[No Abstract] [Full Text] [Related]
42. NSAID--induced gastroduodenal ulcers: exploring the silent dilemma.
Mohamed AH; Salena BJ; Hunt RH
J Gastroenterol; 1994 Jul; 29 Suppl 7():34-8. PubMed ID: 7921152
[TBL] [Abstract][Full Text] [Related]
43. [The drug treatment of gastric and duodenal peptic ulcer].
Grigor'ev PIa
Ter Arkh; 1995; 67(4):73-8. PubMed ID: 7784986
[No Abstract] [Full Text] [Related]
44. Audit of the change of outcome of peptic ulcer disease following treatment of Helicobacter pylori.
Jost C; Marbet UA
Schweiz Med Wochenschr; 1998 Jan; 128(3):64-71. PubMed ID: 9498257
[TBL] [Abstract][Full Text] [Related]
45. Clinical utility and cost effectiveness of Helicobacter pylori testing for patients with duodenal and gastric ulcers.
Greenberg PD; Koch J; Cello JP
Am J Gastroenterol; 1996 Feb; 91(2):228-32. PubMed ID: 8607485
[TBL] [Abstract][Full Text] [Related]
46. Help Desk Answers: What is the optimal duration of PPI therapy for healing an ulcer?
Whealon SR; Gibbs LM
J Fam Pract; 2015 Dec; 64(12):805, 813. PubMed ID: 26845003
[No Abstract] [Full Text] [Related]
47. [The role of the enzymatic antioxidant system and Helicobacter pylori infection in the pathogenesis of peptic ulcer and their effect on treatment efficacy].
Esedov EM; Muradova VR; Mamaev SN
Ter Arkh; 1999; 71(2):19-22. PubMed ID: 10222547
[TBL] [Abstract][Full Text] [Related]
48. [Helicobacter pylori: from harmless commensal to clinically significant disease factor].
Labenz J; Börsch G
Dtsch Med Wochenschr; 1992 Jun; 117(25):997-9. PubMed ID: 1611970
[No Abstract] [Full Text] [Related]
49. [Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].
Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A
Rev Esp Enferm Dig; 1998 Sep; 90(9):655-64. PubMed ID: 9780802
[TBL] [Abstract][Full Text] [Related]
50. Helicobacter pylori in the stomach--a paradox unmasked.
Parsonnet J
N Engl J Med; 1996 Jul; 335(4):278-80. PubMed ID: 8657247
[No Abstract] [Full Text] [Related]
51. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
[TBL] [Abstract][Full Text] [Related]
52. [Should ulcer treatment be aimed against Helicobacter pylori?].
Vatn MH; Guldvog I; Berstad A; Bjørneklett A; Melby K; Skar V; Aase S
Tidsskr Nor Laegeforen; 1991 Jan; 111(2):219. PubMed ID: 1998186
[No Abstract] [Full Text] [Related]
53. Effect of chronic acid inhibition on duodenal bulb gastric metaplasia and Helicobacter pylori.
Dogăn UB; Tunçer C; Dursun A; Kandilci U
Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):235-6. PubMed ID: 9675669
[No Abstract] [Full Text] [Related]
54. Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers.
Deakin M; Williams JG
Drugs; 1992 Nov; 44(5):709-19. PubMed ID: 1280563
[TBL] [Abstract][Full Text] [Related]
55. [When to look for Helicobacter pylori?].
Delchier JC
Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S34-S37. PubMed ID: 8734368
[No Abstract] [Full Text] [Related]
56. Helicobacter pylori and tolerance to H2-blockers.
Zentilin P; Savarino E; Savarino V
Aliment Pharmacol Ther; 2005 Feb; 21(3):289-90; author reply 290-1. PubMed ID: 15691304
[No Abstract] [Full Text] [Related]
57. [Supraselective vagotomy. Long-term results in the treatment of duodenal ulcer].
de Mestier P; Vallot T
Presse Med; 1992 Jun; 21(22):1014-6. PubMed ID: 1354868
[No Abstract] [Full Text] [Related]
58. [Clinical significance of clearing Helicobacter pylori in the treatment of peptic ulcer].
Kori Y; Kato T
Nihon Naika Gakkai Zasshi; 1995 Jun; 84(6):911-5. PubMed ID: 7658124
[No Abstract] [Full Text] [Related]
59. [Recent progress in diagnosis and treatment of digestive diseases. I. Chronic gastritis and peptic ulcer. 3. Drug treatment of peptic ulcer disease-including maintenance therapy in the prevention of recurrence].
Ohshiba S
Nihon Naika Gakkai Zasshi; 1988 Nov; 77(11):1646-50. PubMed ID: 2907909
[No Abstract] [Full Text] [Related]
60. Uncomplicated peptic ulcer disease. An overview of formation and treatment principles.
Ziller SA; Netchvolodoff CV
Postgrad Med; 1993 Mar; 93(4):126-8, 131-2, 137-40. PubMed ID: 8095330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
